Nurse Practitioner, Acute Care · Nashville, TN
NPI
1659678043
Since 2011
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3601 the Vanderbilt Clinic
Nashville, TN, 37232
Phone (615) 322-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
470 services
Medicare patients, 2024
161
Average age 73
Drug cost, 2024
$3.9M
745 prescriptions
Company payments, 2025
$1,427
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathryn E Kennedy was code 99215 (office e&m - established), 234 times for 73 patients. In total Kathryn E Kennedy billed 470 services in 7 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 234 | 73 | $87.56 | $20K |
| 99214 Office E&M - Established | Facility | 109 | 41 | $60.79 | $6,626 |
| 38222 Other Organ Systems | Facility | 81 | 74 | $46.43 | $3,761 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 25 | 17 | $18.17 | $454 |
By year: 2022 $40K for 530 services; 2023 $31K for 437 services; 2024 $33K for 470 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kathryn E Kennedy prescribed most often to Medicare patients was Valacyclovir (Valacyclovir Hcl), with 64 prescriptions and refills. In total Kathryn E Kennedy wrote 745 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Valacyclovir Valacyclovir Hcl | 64 | 138 | 25 | $3,644 |
| Jakafi Ruxolitinib Phosphate | 51 | 51 | Under 11 | $1.1M |
| Allopurinol Generic | 40 | 108 | 16 | $590 |
| Levofloxacin Generic | 37 | 39 | 14 | $317 |
| Inqovi Decitabine/Cedazuridine | 35 | 35 | Under 11 | $279K |
| Ondansetron Hcl Generic | 29 | 30 | 23 | $633 |
| Sprycel Dasatinib | 23 | 23 | Under 11 | $230K |
| Gabapentin Generic | 18 | 28 | Under 11 | $303 |
| Scemblix Asciminib Hydrochloride | 17 | 17 | Under 11 | $872K |
| Oxycodone Hcl Generic | 16 | 16 | Under 11 | $257 |
| Venclexta Venetoclax | 15 | 15 | Under 11 | $63K |
| Hydroxyurea Generic | 15 | 31 | Under 11 | $433 |
| Cefdinir Generic | 14 | 20 | Under 11 | $694 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 13 | 26 | Under 11 | $127 |
| Prochlorperazine Maleate Generic | 12 | 12 | Under 11 | $466 |
Brand drugs: - claims; generic drugs: 514 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathryn E Kennedy $1,427 ($1,427 in general payments such as food, travel and fees) from 4 companies. The largest payer was Pfizer Inc. with $1,162.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.